Regional lung function in patients with chronic bronchitis.

Frequency dependence of compliance as a test for obstruction in the small airways. J Clin Invest (1969) 2.99

The Use of a Helium-Oxygen Mixture during Maximum Expiratory Flow to Demonstrate Obstruction in Small Airways in Smokers. J Clin Invest (1975) 1.93

Regional lung function in patients with obstructive lung diseases. Br Med J (1970) 1.15

Closing volume: a reappraisal (1967-2007). Eur J Appl Physiol (2007) 0.98

Regional pulmonary ventilation and perfusion distribution in patients with untreated idiopathic scoliosis. Thorax (1972) 0.87

Mast cell density in isolated monkey lungs on exposure to cigarette smoke. Thorax (1982) 0.81

"Small airways disease" in children: no test is best. Thorax (1979) 0.81

Vertical gradients in regional alveolar oxygen tension in supine human lung imaged by hyperpolarized 3He MRI. NMR Biomed (2014) 0.79

Regional air trapping before and after exercise in young adults with cystic fibrosis. West J Med (1986) 0.78

Regional Fractional Ventilation by Using Multibreath Wash-in (3)He MR Imaging. Radiology (2016) 0.77

Bronchography in chronic bronchitis. Thorax (1975) 0.77

Disorders of the distal airways. Br Med J (1971) 0.75

Scintigraphic evidence for relief of airways obstruction in cystic fibrosis. J Natl Med Assoc (1988) 0.75

Enzymes and emphysema. Br Med J (1973) 0.75

Canada's contribution to respiratory physiology and pathophysiology. Can Respir J (2007) 0.75

Enzyme deficiency and emphysema. Br Med J (1971) 0.75

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med (1987) 8.41

Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med (2001) 4.48

Mortality in COPD: Role of comorbidities. Eur Respir J (2006) 4.14

Heterogeneity of mouse helper T cells. Evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells. J Immunol (1990) 3.86

Air pollution and hospital admissions in Southern Ontario: the acid summer haze effect. Environ Res (1987) 3.35

Health effects of particulate air pollution: time for reassessment? Environ Health Perspect (1995) 3.29

Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis (1986) 3.03

Relationship between air pollutant levels and hospital admissions in Southern Ontario. Can J Public Health (1983) 2.91

Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers. Eur Respir J (2006) 2.85

Airways obstruction and the risk for lung cancer. Ann Intern Med (1987) 2.77

Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax (2005) 2.69

Airway closure as a function of age. Respir Physiol (1969) 2.53

Respiratory hospital admissions and summertime haze air pollution in Toronto, Ontario: consideration of the role of acid aerosols. Environ Res (1994) 2.47

C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax (2006) 2.38

The fate of the chronic bronchitic: a report of the ten-year follow-up in the Canadian Department of Veteran's Affairs coordinated study of chronic bronchitis. The J. Burns Amberson Lecture of the American Thoracic Society. Am Rev Respir Dis (1973) 2.36

Regional distribution of ventilation and perfusion as a function of body position. J Appl Physiol (1966) 2.20

Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med (2001) 2.03

Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis (1989) 2.03

Associations of IL6 polymorphisms with lung function decline and COPD. Thorax (2009) 2.00

The flow volume loop: normal standards and abnormalities in chronic obstructive pulmonary disease. Chest (1973) 1.91

Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis (1986) 1.87

Steroid response in stable chronic obstructive pulmonary disease. Ann Intern Med (1982) 1.80

Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Eur Respir J (2008) 1.76

Association of IL-1beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers. Thorax (2001) 1.72

Bone marrow changes in anorexia nervosa are correlated with the amount of weight loss and not with other clinical findings. Am J Clin Pathol (2002) 1.72

Regional distribution of pulmonary ventilation and perfusion in elderly subjects. J Clin Invest (1968) 1.71

Regional distribution of pulmonary ventilation and perfusion in obesity. J Clin Invest (1967) 1.68

Deposition and retention models for internal dosimetry of the human respiratory tract. Task group on lung dynamics. Health Phys (1966) 1.61

Increased serum levels of CD44s and CD44v6 in patients with AIDS-related non-Hodgkin's lymphoma. AIDS (2000) 1.57

Distribution of pulmonary perfusion in erect man. J Appl Physiol (1966) 1.57

Air pollution: time for more clean air legislation? BMJ (1996) 1.54

Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology. Haematologica (1998) 1.48

Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL. Haematologica (1998) 1.47

SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status. Leukemia (2012) 1.45

Heart and lung functions in swimmers and nonathletes during growth. J Appl Physiol (1972) 1.44

Income level and asthma prevalence and care patterns. Am J Respir Crit Care Med (1997) 1.44

Comparison of responses to methacholine and cold air in patients suspected of having asthma. Chest (1989) 1.40

Asbestos: the turbulent interface between science and policy. CMAJ (1991) 1.36

Prevalence of asthma symptoms among adults aged 20-44 years in Canada. CMAJ (2001) 1.33

Short-term effects of ozone on the lung. J Appl Physiol (1972) 1.33

Exercise training: therapy for patients with chronic obstructive pulmonary disease. Chest (1970) 1.31

Mechanism of action of ozone on the human lung. J Appl Physiol (1985) (1989) 1.28

Trends in physician-diagnosed asthma prevalence in Manitoba between 1980 and 1990. Chest (1993) 1.27

Effect of inspiratory flow rate on regional distribution of inspired gas. J Appl Physiol (1969) 1.27

Vibration white finger disease among tree fellers in British columbia. J Occup Med (1983) 1.27

Regional structure and function in bronchiectasis. A correlative study using bronchography and 133Xe. Am Rev Respir Dis (1968) 1.26

Problems in studies of human exposure to air pollutants. Can Med Assoc J (1970) 1.24

Pulmonary function in man after short-term exposure to ozone. Arch Environ Health (1973) 1.24

Historical review: the carbon monoxide diffusing capacity (DLCO) and its membrane (DM) and red cell (Theta.Vc) components. Respir Physiol Neurobiol (2003) 1.20

Asbestos: promotion or prohibition? CMAJ (1987) 1.19

Human lung homotransplantation. Can Med Assoc J (1966) 1.16

Predicting episodes of poor asthma control in treated patients with asthma. J Allergy Clin Immunol (2006) 1.16

Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma. Leukemia (2011) 1.16

Ventilatory response to sustained hypoxia in normal adults. J Appl Physiol (1985) (1986) 1.14

Effects of multiple attempts to quit smoking and relapses to smoking on pulmonary function. Lung Health Study Research Group. J Clin Epidemiol (1998) 1.13

Endogenous opiates and chemical control of breathing in humans. Am Rev Respir Dis (1980) 1.12

Limitations of indicator-dilution methods in experimental shock. J Appl Physiol (1967) 1.12

A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence. N Engl J Med (1986) 1.12

Hemodynamic studies in cardiogenic shock. Treatment with isoproterenol and metaraminol. Circulation (1967) 1.12

Long-term oxygen therapy. Ann Intern Med (1983) 1.11

Geographical variations in the prevalence of atopic sensitization in six study sites across Canada. Allergy (2010) 1.11

Ventilatory response to moderate hypoxia in awake chemodenervated cats. J Appl Physiol (1985) (1993) 1.11

Combined effect of ozone and sulphur dioxide on human pulmonary function. Nature (1975) 1.11

Natural killer lines and clones with apparent antigen specificity. J Exp Med (1990) 1.10

Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III. J Lipid Res (1992) 1.10

[Primary gastrointestinal lymphomas: response to eradicative therapy and prognostic factors in 52 patients]. Med Clin (Barc) (1998) 1.07

The prevention of emphysema. Chest (1974) 1.06

Regional lung function in patients with bronchial asthma. J Clin Invest (1968) 1.04

Air pollutants and the human lung. The James Waring memorial lecture. Am Rev Respir Dis (1972) 1.04

Carbohydrate binding proteins involved in phagocytosis by Acanthamoeba. Nature (1975) 1.03

Respiratory symptoms in a susceptible population due to burning of agricultural residue. Chest (1998) 1.02

Respiratory effects of exposure to ozone plus sulfur dioxide in Southern Californians and Eastern Canadians. Am Ind Hyg Assoc J (1977) 1.02

Regulation of bone marrow stromal cell differentiation by cytokines whose receptors share the gp130 protein. J Cell Biochem (1994) 1.02

Smoking, lung function, and mortality. Thorax (2000) 1.00

Polymorphisms in the beta2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers. Thorax (2003) 0.99

Characteristics of participants who stop smoking and sustain abstinence for 1 and 5 years in the Lung Health Study. Prev Med (2000) 0.99

Lung Health Study. Am Rev Respir Dis (1989) 0.99

Ventilatory control in patients with hypoxemia due to obstructive lung disease. Am Rev Respir Dis (1979) 0.99

Effects of physical training on hemodynamics and pulmonary function at rest and during exercise in patients with chronic obstructive pulmonary disease. Chest (1974) 0.98

Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients. Leukemia (2012) 0.97

Chemical control of ventilation and sleep arterial oxygen desaturation in patients with COPD. Am Rev Respir Dis (1980) 0.97

Saccharomyces cerevisiae septicemia in a patient with myelodysplastic syndrome. Am J Hematol (1993) 0.96

Pulmonary function with acute loss of excess lung water by hemodialysis in patients with chronic uremia. Am J Med (1973) 0.96

Indicator-dilution methods in estimation of cardiac output in clinical shock. Am J Cardiol (1967) 0.96

Air pollution: political initiative, scientific reality, and the process of decision making. Lung (1979) 0.96

Mechanics of breathing in mitral stenosis. Am Rev Respir Dis (1971) 0.94

Recovery of the ventilatory response to hypoxia in normal adults. J Appl Physiol (1985) (1988) 0.94

Limitations of indicator dilution methods in estimation of cardiac output in chronic lung disease. Am Heart J (1968) 0.94

Effect of meperidine on occlusion pressure responses to hypercapnia and hypoxia with and without external inspiratory resistance. Am Rev Respir Dis (1976) 0.93

Hypoxic exposure and activation of the afterdischarge mechanism in conscious humans. J Appl Physiol (1985) (1990) 0.93

Effect of inspiratory resistance of occlusion pressure in hypoxia and hypercapnia. Respir Physiol (1975) 0.93

Regional pulmonary gas exchange in patients with pulmonary embolism. Clin Sci (1967) 0.92

Different lymphoid cell populations produce varied levels of neopterin, beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha. Clin Exp Immunol (1992) 0.92

Recruiting healthy participants for a large clinical trial. Control Clin Trials (1993) 0.92

Steady state measurement of regional ventilation to perfusion ratios in normal man. J Clin Invest (1966) 0.91